Umbilical cord-derived mesenchymal stem cells for treatment of liver cirrhosis
The aim of this study is to assess the safety and efficacy of umbilical cord-derived mesenchymal stem cell (UC-MSCs) transplantation in patients with liver cirrhosis.
Read More
No additional information regarding the therapeutic cells was provided by the sponsor.
Read More
Product Information for
Umbilical cord-derived mesenchymal stem cells for treatment of liver cirrhosis